BRIEF-Galapagos initiates first phase 1 study in cystic fibrosis

* Galapagos initiates first phase 1 study in cystic fibrosis and will receive milestone payment from Abbvie
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.